Use of anti-viral therapies in hospitalised COVID-19 patients in the United Arab Emirates: a cost-effectiveness and health-care resource use analysis

BACKGROUND: This study attempts to estimate the cost-effectiveness of the antiviral remdesivir, as recommended in the 2021 COVID treatment guidelines for the United Arab Emirates, compared to standard of care (SOC), but also favipiravir (FAVI), which was also recommended for the treatment of hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhi, Ahmad, Shamy, Amin Mohamed El, Hussein, Saeed Abdullah Mohammed, Jarrett, James, Kozma, Sam, Harfouche, Camille, Al Dallal, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116096/
https://www.ncbi.nlm.nih.gov/pubmed/37081467
http://dx.doi.org/10.1186/s12913-023-09376-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116096/
https://www.ncbi.nlm.nih.gov/pubmed/37081467
http://dx.doi.org/10.1186/s12913-023-09376-w

Ejemplares similares